Clinical Trial Update: Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the therapeutic action of tamsulosin and finasteride in symptomatic benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• FINASTERIDE (FINASTERIDE)
• Tamsulosin (tamsulosin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Prostatic Hyperplasia | Phase 4 | Status: COMPLETED